Agriculture made from cells in a facility, not plants on a field.
Headquarters Boston, Massachusetts, United States
GALY is a developer of cellular agriculture using biotechnology and sustainable, less energy-land-intensive methods to produce natural products. The company creates cotton in a laboratory context from cells utilizing a proprietary method instead of field farming that is faster, higher quality, and cheaper than natural cotton, with a drastically lower environmental impact. GALY’s cell-culture platform can be applied to produce products beyond Cotton; it is currently trialling its cotton products with customers but is prototyping cocoa, with more products in the R&D pipeline. The company has raised its Series A in 2021, with which it is building the foundations of the business and market testing its products with customers. Going forward, it plans to build a pilot plant and validate its low CapEx production facilities and develop new cell culture products. On its hyper-scale plan, GALY will build 5 Giga factories in 5 different continents with 200,000 tons/yr production capacity each and 1,000 modular low-CapEx facilities to produce its products all over the globe and significantly lower its cost profile.
- Raised over USD 32M to date. Investors include John Doerr, Sergey Brin, Material Impact, Sam Altman, Tony Fadell, Emily Leproust, and others
- 1st place on H&M Global Change Awards - the nobel prize for sustainability - from more than 4,000+ companies
- 1st place on Sutainability category for the LVMH Innovation Awards
Currently Operating in Two Regions
Work at GALY
Get the Unreasonable Newsletter
Get monthly updates on GALY and over 381 other ventures working to solve the world's toughest problems.
Must select the list to subscribe to.